Search Results - "Varagunam, M"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Changes in volume, clinical practice and outcome after reorganisation of oesophago-gastric cancer care in England: A longitudinal observational study by Varagunam, M., Hardwick, R., Riley, S., Chadwick, G., Cromwell, D.A., Groene, O.

    Published in European journal of surgical oncology (01-04-2018)
    “…The centralisation of oesophago-gastric (O-G) cancer services in England was recommended in 2001, partly because of evidence for a volume-outcome effect for…”
    Get full text
    Journal Article
  2. 2

    Brachytherapy in the Palliation of Oesophageal Cancer: Effective but Impractical? by Sinha, S., Varagunam, M., Park, M.H., Maynard, N.D., Trudgill, N., Crosby, T., Cromwell, D.A.

    “…Dysphagia in people with advanced oesophageal cancer can be treated by oesophageal stents, external beam radiotherapy (EBRT) and intraluminal brachytherapy…”
    Get full text
    Journal Article
  3. 3

    Population-based cohort study of the management and survival of patients with early-stage oesophageal adenocarcinoma in England by Chadwick, G., Riley, S., Hardwick, R. H., Crosby, T., Hoare, J., Hanna, G., Greenaway, K., Varagunam, M., Cromwell, D. A., Groene, O.

    Published in British journal of surgery (01-04-2016)
    “…Background Until recently, oesophagectomy was the treatment of choice for early oesophageal cancer. Endoscopic treatment has been introduced relatively…”
    Get full text
    Journal Article
  4. 4

    Influence of surgical rate on patients' reported clinical need and outcomes in English NHS by Black, N., Varagunam, M., Hutchings, A.

    Published in Journal of public health (Oxford, England) (01-09-2014)
    “…Background To determine if higher rates of surgery are associated with lower levels of need (patients' pre-operative reports of their symptoms, functional…”
    Get full text
    Journal Article
  5. 5

    Pretransplant Donor-Specific Antibodies in Cytotoxic Negative Crossmatch Kidney Transplants : Are They Relevant? by WAGNER, Martin, ZOLLNER, Gernot, TRAUNER, Michael, GUPTA, Arun, IVESON, Victoria, VARAGUNAM, Mira, BODGER, Stephen, SINNOTT, Paul, THURAISINGHAM, Raj C

    Published in Transplantation (27-04-2008)
    “…The corresponding antigens of alloantibodies identified in patients awaiting kidney transplantation are often listed as unacceptable for transplantation. The…”
    Get full text
    Journal Article
  6. 6

    High glucose‐induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases by Allen, David A., Harwood, Steven M., Varagunam, Mira, Raftery, Martin J., Yaqoob, Muhammad M.

    Published in The FASEB journal (01-05-2003)
    “…ABSTRACT Diabetic nephropathy is the leading cause of end‐stage renal disease in the Western world. Poor glycemic control contributes to the development of…”
    Get full text
    Journal Article
  7. 7

    Anti‐idiotypic activity against anti‐myeloperoxidase antibodies in pooled human immunoglobulin by PALL, A. A., VARAGUNAM, M., ADU, D., SMITH, N., RICHARDS, N. T., TAYLOR, C. M., MICHAEL, J.

    Published in Clinical and experimental immunology (01-02-1994)
    “…SUMMARY We investigated the ability of six different pooled human immunoglobulin (PHIG) preparations to inhibit the binding of anti‐myeloperoxidase (MPO)…”
    Get full text
    Journal Article
  8. 8

    Creatinine reduction ratio: a useful marker to identify medium and high-risk renal transplants by Vilar, Enric, Varagunam, Mira, Yaqoob, Muhammad M, Raftery, Martin, Thuraisingham, Raj

    Published in Transplantation (15-01-2010)
    “…Delayed graft function (DGF) has a major impact on long-term renal transplant survival. However, it is a diagnosis made retrospectively with little opportunity…”
    Get full text
    Journal Article
  9. 9

    Little evidence for anti-endothelial cell antibodies in microscopic polyarteritis and Wegener's granulomatosis by Varagunam, M, Nwosu, Z, Adu, D, Garner, C, Taylor, C M, Michael, J, Thompson, R A

    “…We studied sera from patients with vasculitis and controls for the presence of anti-endothelial cell antibodies (AECA) and correlated these with disease type,…”
    Get more information
    Journal Article
  10. 10
  11. 11

    High Pre‐Transplant Soluble CD30 Levels are Predictive of the Grade of Rejection by Rajakariar, Ravindra, Jivanji, Naina, Varagunam, Mira, Rafiq, Mohammad, Gupta, Arun, Sheaff, Michael, Sinnott, Paul, Yaqoob, MM

    Published in American journal of transplantation (01-08-2005)
    “…In renal transplantation, serum soluble CD30 (sCD30) levels in graft recipients are associated with increased rejection and graft loss. We investigated whether…”
    Get full text
    Journal Article
  12. 12

    Pooled human IGG (PHIG) inhibits the binding of anti-myeloperoxidase antibodies to myeloperoxidase by Pall, A A, Varagunam, M, Adu, D, Smith, N, Taylor, C M, Michael, J

    “…This study demonstrates that pooled human immunoglobulin (PHIG) contains anti-idiotypes to anti-myeloperoxidase (MPO) antibodies and can inhibit the binding of…”
    Get more information
    Journal Article
  13. 13

    Little evidence for anti-endothelial-cell antibodies in microscopic polyarteritis and Wegener's granulomatosis by Varagunam, M, Nwosu, A C, Adu, D, Garner, C, Taylor, C M, Michael, J, Thompson, R A

    “…Sera from patients with a vasculitis and controls were investigated for the presence of anti-endothelial cell antibodies(AECA), anti- neutrophil cytoplasmic…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients by Varagunam, Mira, Finney, Hazel, Trevitt, Ray, Sharples, Edward, McCloskey, Daniel J., Sinnott, Paul J., Raftery, Martin J., Yaqoob, Muhammad M.

    Published in American journal of kidney diseases (01-03-2004)
    “…Background: Chronic inflammation, the common pathway that leads to cardiovascular disease and chronic allograft nephropathy after transplantation, is prevalent…”
    Get full text
    Journal Article
  16. 16

    THE EFFECT OF PROINFLAMMATORY CYTOKINE GENE AND ANGIOTENSIN-CONVERTING ENZYME POLYMORPHISMS ON ERYTHROPOIETIN REQUIREMENTS IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS by Sharples, Edward J, Varagunam, Mira, Sinnott, Paul J, McCloskey, Daniel J, Raftery, Martin J, Yaqoob, Mohammad M

    Published in Peritoneal dialysis international (01-01-2006)
    “…Department of Renal Medicine and Transplantation, 1 Royal London and St Bartholomew's Hospital; Tissue Typing Laboratory, 2 Royal London Hospital, Whitechapel,…”
    Get full text
    Journal Article
  17. 17

    Cytokines in haemolytic uraemic syndrome associated with verocytotoxin-producing Escherichia coli infection by Inward, C D, Varagunam, M, Adu, D, Milford, D V, Taylor, C M

    Published in Archives of disease in childhood (01-08-1997)
    “…The proinflammatory cytokines tumour necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-6, and IL-8 were measured in plasma and urine samples from 19 children…”
    Get full text
    Journal Article
  18. 18

    Angiotensin-converting enzyme gene polymorphism and erythropoietin requirement by Varagunam, M, McCloskey, DJ, Sinnott, PJ, Raftery, MJ, Yaqoob, MM

    Published in Peritoneal dialysis international (01-03-2003)
    “…Experimental Medicine and Nephrology, St. Bartholomews and the Royal London Medical School, London, United Kingdom. m.varagunam@qmul.ac.uk…”
    Get full text
    Journal Article